Atlantic Healthcare strengthens Board with seasoned industry veterans Robert Dow and Julian Thurston

Cambridge, UK; 7th June 2021 Atlantic Healthcare plc (Atlantic Healthcare), the…


Atlantic Healthcare attends virtual Digestive Disease Week®

Cambridge, UK; 24th May 2021 Atlantic Healthcare plc (“Atlantic Healthcare” or…


Atlantic Healthcare to attend IBD UK conference

Cambridge, UK; 26th April 2021 Atlantic Healthcare plc to attend a…


The effects of renzapride, a novel prokinetic agent, in diabetic gastroparesis

Mackie ADR, Ferrington C, Cowan S & Palmer KR. (1991) Alimentary…


Effects of cisapride in patients with cystic fibrosis and distal intestinal obstruction syndrome

Koletzko, S., Corey, M., Ellis, L., Spino, M., Stringer, D. A., & Durie, P.…


Is Gastroparesis Found More Frequently in Patients with Cystic Fibrosis? A Systematic Review

Corral JE, Corey WD, Mascarenhas MR, Barkin JS, Salathe M & Moshiree B…


Minimally Important Differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument

Khanna, D. et al. (2011) Journal of Rheumatology, 38(9), pp. 1920–1924. doi:…


Late-Age Onset Scleroderma

Manno, R. L. et al. (2011) Journal of Rheumatology, 38(7), pp. 1317– 1325.…


Renzapride in IBS: is efficacy in the eye of the beholder?

Ford AC (2010) Alimentary Pharmacology and Therapeutics, 113 View article